SISRAM MED (01696): Lior Moshe DAYAN Appointed as Executive Director, Chairman, Nomination Committee Chairman, and Authorized Representative

Stock News12-08

SISRAM MED (01696) announced that effective January 1, 2026, current Executive Director and Board Chairman Mr. Liu Yi will transition to a Non-Executive Director role due to internal group reassignment. He will step down as Chairman, Chairman of the Board Nomination Committee, member of the Board Remuneration Committee, and the company’s authorized representative. Mr. Liu will retain his position as a member of the Nomination Committee.

Current Executive Director and CEO Mr. Lior Moshe DAYAN will assume the roles of Executive Director, Chairman, Chairman of the Nomination Committee, and authorized representative. Due to internal group reassignment, he will no longer serve as CEO.

Current Non-Executive Director Ms. Feng Rongli will join the Remuneration Committee, while current Independent Non-Executive Director Mr. Chen Zhifeng will become a member of the Nomination Committee.

Mr. Eyal BEN DAVID, current Group Global Business President, will take over as CEO. Concurrently, Mr. Li Jiahong, Executive Director and CFO, will serve as Co-CEO.

Mr. Wu Yifang will resign as Non-Executive Director effective January 1, 2026, due to work reassignment. Ms. Caroline Xiaokui JIN has been appointed as a Non-Executive Director, effective the same date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1110610411?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-08 21:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110610411","market":"sg","top_or_hot":-1,"title":"SISRAM MED (01696): Lior Moshe DAYAN Appointed as Executive Director, Chairman, Nomination Committee Chairman, and Authorized Representative","media":"Stock News","content":"<p>SISRAM MED (01696) announced that effective January 1, 2026, current Executive Director and Board Chairman Mr. Liu Yi will transition to a Non-Executive Director role due to internal group reassignment. He will step down as Chairman, Chairman of the Board Nomination Committee, member of the Board Remuneration Committee, and the company’s authorized representative. Mr. Liu will retain his position as a member of the Nomination Committee.</p>\n<p>Current Executive Director and CEO Mr. Lior Moshe DAYAN will assume the roles of Executive Director, Chairman, Chairman of the Nomination Committee, and authorized representative. Due to internal group reassignment, he will no longer serve as CEO.</p>\n<p>Current Non-Executive Director Ms. Feng Rongli will join the Remuneration Committee, while current Independent Non-Executive Director Mr. Chen Zhifeng will become a member of the Nomination Committee.</p>\n<p>Mr. Eyal BEN DAVID, current Group Global Business President, will take over as CEO. Concurrently, Mr. Li Jiahong, Executive Director and CFO, will serve as Co-CEO.</p>\n<p>Mr. Wu Yifang will resign as Non-Executive Director effective January 1, 2026, due to work reassignment. Ms. Caroline Xiaokui JIN has been appointed as a Non-Executive Director, effective the same date.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SISRAM MED (01696): Lior Moshe DAYAN Appointed as Executive Director, Chairman, Nomination Committee Chairman, and Authorized Representative</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSISRAM MED (01696): Lior Moshe DAYAN Appointed as Executive Director, Chairman, Nomination Committee Chairman, and Authorized Representative\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-08 21:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SISRAM MED (01696) announced that effective January 1, 2026, current Executive Director and Board Chairman Mr. Liu Yi will transition to a Non-Executive Director role due to internal group reassignment. He will step down as Chairman, Chairman of the Board Nomination Committee, member of the Board Remuneration Committee, and the company’s authorized representative. Mr. Liu will retain his position as a member of the Nomination Committee.</p>\n<p>Current Executive Director and CEO Mr. Lior Moshe DAYAN will assume the roles of Executive Director, Chairman, Chairman of the Nomination Committee, and authorized representative. Due to internal group reassignment, he will no longer serve as CEO.</p>\n<p>Current Non-Executive Director Ms. Feng Rongli will join the Remuneration Committee, while current Independent Non-Executive Director Mr. Chen Zhifeng will become a member of the Nomination Committee.</p>\n<p>Mr. Eyal BEN DAVID, current Group Global Business President, will take over as CEO. Concurrently, Mr. Li Jiahong, Executive Director and CFO, will serve as Co-CEO.</p>\n<p>Mr. Wu Yifang will resign as Non-Executive Director effective January 1, 2026, due to work reassignment. Ms. Caroline Xiaokui JIN has been appointed as a Non-Executive Director, effective the same date.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01696","symbol_name":"复锐医疗科技","start_time":0,"source_url":"","article_id":"1110610411","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110610411","pubTimestamp":1765201099,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"SISRAM MED (01696) announced that effective January 1, 2026, current Executive Director and Board Chairman Mr. Liu Yi will transition to a Non-Executive Director role due to internal group...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01696":"复锐医疗科技","BK1100":"医疗保健设备","BK1593":"医美概念股","BK1585":"昨日强势股"},"translate_title":"SISRAM MED(01696)：Lior Moshe DAYAN获委任为执行董事、主席、提名委员会主席、授权代表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01696":1},"content_text":"SISRAM MED (01696) announced that effective January 1, 2026, current Executive Director and Board Chairman Mr. Liu Yi will transition to a Non-Executive Director role due to internal group reassignment. He will step down as Chairman, Chairman of the Board Nomination Committee, member of the Board Remuneration Committee, and the company’s authorized representative. Mr. Liu will retain his position as a member of the Nomination Committee.\nCurrent Executive Director and CEO Mr. Lior Moshe DAYAN will assume the roles of Executive Director, Chairman, Chairman of the Nomination Committee, and authorized representative. Due to internal group reassignment, he will no longer serve as CEO.\nCurrent Non-Executive Director Ms. Feng Rongli will join the Remuneration Committee, while current Independent Non-Executive Director Mr. Chen Zhifeng will become a member of the Nomination Committee.\nMr. Eyal BEN DAVID, current Group Global Business President, will take over as CEO. Concurrently, Mr. Li Jiahong, Executive Director and CFO, will serve as Co-CEO.\nMr. Wu Yifang will resign as Non-Executive Director effective January 1, 2026, due to work reassignment. Ms. Caroline Xiaokui JIN has been appointed as a Non-Executive Director, effective the same date.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1110610411","isCrawlerRequest":true}